TransMedics Group, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TransMedics Group, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q3 2024.
  • TransMedics Group, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $322K, a 77.1% decline year-over-year.
  • TransMedics Group, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.2M, a 37.2% increase year-over-year.
  • TransMedics Group, Inc. annual Nonoperating Income (Expense) for 2023 was $2.06M.
  • TransMedics Group, Inc. annual Nonoperating Income (Expense) for 2022 was -$4.73M, a 0.48% increase from 2021.
  • TransMedics Group, Inc. annual Nonoperating Income (Expense) for 2021 was -$4.75M, a 104% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.2M $322K -$1.08M -77.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $2.28M -$355K -$281K -380% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $2.56M -$28K +$508K +94.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $2.06M $1.26M +$1.18M +1515% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $874K $1.41M +$3.27M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$2.4M -$74K +$1.68M +95.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$4.08M -$536K +$651K +54.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$4.73M $78K +$1.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$6.13M -$1.86M -$635K -51.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$5.49M -$1.76M -$962K -121% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$4.53M -$1.19M +$219K +15.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$4.75M -$1.32M -$918K -227% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$3.83M -$1.23M -$756K -160% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$3.08M -$794K -$164K -26% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$2.91M -$1.41M -$581K -70.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$2.33M -$405K +$68K +14.4% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$2.4M -$472K +$556K +54.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$2.96M -$630K +$850K +57.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$3.81M -$825K +$98K +10.6% Dec 29, 2019 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$3.9M -$473K +$783K +62.3% Sep 29, 2019 Dec 28, 2019 10-K 2021-03-11
Q3 2019 -$4.69M -$1.03M +$130K +11.2% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-06
Q2 2019 -$4.82M -$1.48M -$529K -55.6% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-10
Q1 2019 -$4.29M -$923K -$810K -717% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-06
Q4 2018 -$3.48M -$1.26M Sep 30, 2018 Dec 29, 2018 10-K 2020-03-17
Q3 2018 -$1.16M Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-08
Q2 2018 -$951K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$113K Dec 31, 2017 Mar 31, 2018 10-Q 2019-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.